JHM Biopharma

Hangzhou, China · Founded 2020 · Privately Held (backing)

Provider and developer of biological proteins used as medications. JHM Biopharma is based in Hangzhou, China and was founded in 2020. Its last reported valuation was $160 million in May 2024. It has raised $84.8 million.

Last reported valuation
$159.7M
Oct 2026
Priced at
—
Total raised
$84.8M
Last round
—

Who backs JHM Biopharma?

13 investors
InvestorType
Suzhou Oriza Holdings CorporationAsset manager
SDIC Unity CapitalFund of funds
Shanghai Guofang Private Equity Fund Management CompanyOther
3E Bioventures CapitalVenture capital
China Capital Zhongcai Fund Management—
Focus Fund (Beijing)—
Guangdian Capital—
Hongsheng Capital—
Hoshi Capital—
SoYoung—
+ 3 more investors · a free account shows the complete list
The directory is free. Investor activity — the working column — is Pro.Unlock prospecting columns

Membership and data by Private Market View

JHM Biopharma investors

Free account
More of JHM Biopharma with a free account
  • ·The complete investor list: 13 names
  • ·Watch JHM Biopharma: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

For fundraisers
Work this list, don’t just read it

These 13 firms already write checks for companies like JHM Biopharma. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.

Find investors like these →

Membership and data by Private Market View